DRKS00000227已完成2 期
Vaccination with recombinant lymphoma idiotype in indolent lymphoma in advanced stages - IdvaxII
Abteilung Innere Medizin IUniversitätsklinikum Freiburg0 个研究点目标入组 42 人开始时间: 2009年10月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Confirmed indolent B cell lymphoma
- •Lymphoma biopsy feasible without general anesthesia
- •Age > 18 years
- •Informed consent
排除标准
- •Monclonal paraprotein exceeding the normal concentrations for the respective Ig class
- •Severe concomitant illness or infection
- •Active CNS involvement
- •Systemic antineoplastic therapy, other immunotherapy including steroids four weeks prior to vaccination
- •pregnancy and lactation period
研究者
相似试验
尚未招募
不适用
Response to vaccination in lymphoma patients treated with CHOP and rituximab.cancer of the lymph nodes1004743810025320LymphomaNL-OMON38294Sint Antonius Ziekenhuis160
撤回
不适用
Vaccination response in lymphoma patients treated with CHOP and rituximabB-cell malignancylymph node cancer1002532010004018NL-OMON32777Sint Antonius Ziekenhuis140
已完成
1 期
Vaccination of cancer patients for preventing cancer developmentymphoma.B-cell lymphoma, unspecifiedIRCT138712071715N1Mazandaran University of Medical Sciences10
进行中（未招募）
不适用
Reponse to vaccination in patients with bonemarrowcancer who are treated with chemotherapy.multiple myelomaEUCTR2012-005713-39-NLSt. Antonius Hospital
Unknown
不适用
Vaccinations in persons with a condition affecting the immune system: paramount and paradox.ImmunocompromisedHIVImmunosuppressive medicationStem cell transplantationOrgan transplantationrheumatic diseasesinflammatory bowel diseaseVaccineVaccinationHepatitis A vaccinePneumococcal vaccineImmunogenicityNL-OMON24856Amsterdam UMC (locatie AMC)570